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 Introduction 
 For more than a decade, the biomedical research enterprise 
has been characterized by a distinct shift  toward team-based 
clinical and translational science. 1,2 With this shift  came the 
recognition that existing strategies to train members of the 
research workforce would be inadequate to prepare the research 
teams of the future. Instead, education, training, and career 
development (ETCD) activities must help develop a workforce 
that is diverse in terms of their roles (e.g., principal investigators, 
co-investigators, implementers/collaborators, community 
practitioners, and stakeholders such as patients and advocates), 
individual characteristics, and scientifi c areas (e.g., basic science, 
informatics, biostatistics, and/or clinical experts). 3,4 Because 
research training requires a substantial investment of time and 
resources, an equally pressing need is to retain these trainees in the 
biomedical workforce. 5 For these reasons, ETCD activities were 
required in the NIH Clinical and Translational Science Award 
(CTSA) Program. 
 A recent Institute of Medicine (IOM) report recognized the 
substantial contributions that CTSAs have made in advancing 
clinical and translational research. 6 Th is report also highlighted 
the importance of preparing the future research workforce. In this 
regard, the IOM report off ered recommendations related to ETCD 
activities within CTSAs. First, ETCD programs must: (1) develop 
innovative models that emphasize team science, leadership, 
community engagement, and entrepreneurship; (2) disseminate 
successful activities online for use by the CTSA consortium and 
non-CTSA institutions; (3) champion career development paths 
for investigators conducting clinical and translational research; 
and (4) tailor training to diverse audiences, which may include 
graduate degrees in clinical and translational science. 7 Secondly, 
and more broadly, the IOM committee “envisions a transformation 
of the CTSA Program from its current, loosely organized structure 
into a more tightly integrated network that works collectively to 
. . . disseminate innovative translational research methods and 
best practices. . .” 7 Taken together, these recommendations require 
that CTSAs develop innovative: (1) programs to educate and train 
members of research teams of the future; (2) strategies tailored 
to individuals’ specifi c roles on these teams; and (3) processes to 
evaluate programs and disseminate best practices beyond any 
single CTSA. 
 Given the importance of ETCD activities for clinical and 
translational research that improves population health, it is 
essential to develop and disseminate best practices across the 
CTSA consortium. To this end, the North Carolina Translational 
and Clinical Sciences (NC TraCS) Institute, the integrated home of 
the University of North Carolina-Chapel Hill (UNC-CH) CTSA, 
has developed a four-phase NC TraCS Education Development 
and Evaluation Model ( Figure  1 ). Th e structure of our model 
is based loosely on the four phases of clinical testing for new 
pharmaceutical products. In the subsequent sections, we provide 
a brief overview of this model, as well as examples from our own 
CTSA to illustrate its use in practice. 
 Th e NC TraCS Education Development and Evaluation Model: 
overview 
 In Phase I ( Innovate ), we conduct preliminary small-scale trials of 
programs intended to address specifi c training needs. Given the 
diversity of team members’ roles, we prioritize programs that can be 
tailored to individual trainees using a hybrid learning model that 
includes: (1) didactic courses; (2) individual and team-based cases 
to enhance participants’ ability to solve “real-world” problems; (3) 
panel discussions in which investigators share their experiences 
regarding facilitators, barriers and strategies for success; and 
(4) small groups in which participants provide and receive 
constructive feedback that demonstrates core competencies. 
Typically, evaluation in this phase is based on debriefi ng sessions 
with participants (program faculty and learners), as well as 
preliminary metrics of success (when applicable). To move onto 
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 Abstract 
 With the shift toward team-based translational science came recognition that existing strategies for training individual investigators and 
retaining them in the biomedical workforce would be inadequate. To support this shift, it is important to: develop innovative strategies 
to educate and train diverse members of research teams; evaluate those programs; and disseminate best practices broadly. We have 
developed a four-phase model to facilitate the development, evaluation, and widespread dissemination of innovative strategies to train 
the biomedical research workforce. Phase I (Innovate) involves small scale trials of programs to address perceived training needs or new 
methods of delivery. Phase II (Incubate) refi nes and evaluates promising Phase I activities on a larger scale. Phase III (Translate) seeks 
to replicate initial successes either locally (Phase IIIa) or with other interested institutions (Phase IIIb). Phase IV (Disseminate) assesses 
whether identifi ed local best practices can have success on a broader scale. We present specifi c examples from our own experience 
that demonstrate the utility of this model, and then conclude with opportunities and challenges related to the education and training 
of this workforce. Clin Trans Sci 2014; Volume 7: 402–405 
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Phase II, ETCD leadership must view the program as having the 
potential for broader-scale dissemination at UNC-CH. 
 Phase II ( Incubate ) occurs for those Phase I activities for 
which preliminary data suggests promising results. During Phase 
II, we oft en revise the content and/or structure of the Phase I 
program based upon participants’ evaluations. Phase II involves 
more formal evaluation strategies, including structured interviews 
with participants. In addition, we typically specify key outcomes in 
advance. Notably, Phase II is oft en iterative, and several refi nements 
to the program may be necessary before moving onto Phase III. 
 Phase III ( Translate ) involves evaluating whether initial Phase 
II success can be replicated throughout UNC-CH (Phase IIIa) and/
or within interested members of the CTSA consortium (Phase 
IIIb). Notably, not all programs should or will continue to Phase 
IIIb because the content may be specifi c to local environments 
(e.g., aspects of achieving promotion and tenure). As with Phase 
II, we use debriefi ng sessions with participants and specify key 
outcomes in advance to evaluate these activities. Based on the 
evaluation during Phase III, we will also identify refi nements 
that may be needed before recommending programs for broader 
dissemination in Phase IV. 
 Phase IV ( Disseminate ) focuses on assessing whether we can 
achieve widespread benefi t across the CTSA Consortium. For 
example, one site may provide infrastructure to support a cross-
CTSA activity or simply disseminate best practices across CTSAs. 
It should be noted that for some activities, barriers to cross-CTSA 
participation may be revealed (e.g., protection of confi dentiality, 
data security). Because no program has yet reached Phase IV, we 
have not developed an implementation strategy. We expect to 
standardize the evaluations across sites using both feedback from 
participants and measurable outcomes. 
 Th e NC TraCS Education Development and Evaluation Model: 
examples 
 To demonstrate how we use the NC TraCS Education Development 
and Evaluation Model in practice, we describe three activities: 
mock review program, K-seminar, and R-writing groups ( Table  1 ). 
 Mock review program 
 Mock reviews have been integral to our curriculum for more 
than a decade. We identify a team of expert reviewers and ETCD 
faculty to formally review a junior investigator’s grant proposal 
using the NIH study section format; ideally the reviews occur 
approximately 2 months prior to submission. Our early metrics 
for success included our abilities to: organize and hold mock 
reviews within a suitable time frame; engage expert reviewers; 
and provide investigators with useful feedback that improved 
the quality of their grant proposals. Junior investigators whose 
proposals underwent mock reviews consistently reported that 
the process not only improved the quality of the proposal, but 
also extended the applicant’s scientifi c network. In some cases, 
reviewers served as mentors, collaborators and/or consultants on 
subsequent grants. Besides strengthening individual applications, 
mock reviewers teach observers about the criteria senior 
investigators use to evaluate proposals. Initially ( Figure  2 ), mock 
reviews were arranged for junior faculty supported by our KL2 
and K12 programs only (Phase I); however, the extremely positive 
feedback from participants convinced us to expand mock reviews 
to wider audiences at UNC-CH, including MD/PhD students 
writing NIH F-type proposals (Phase II). We also helped senior 
mentors in departments without formal training programs to 
organize mock reviews for their own mentees (Phase IIIa). As a 
result, the demand for organizing mock reviews grew; however, 
 Figure 1.  NC TraCS Education Development and Evaluation Model. 
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Participant's future activities in 
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 Table 1.  Selected programs, objectives, goals, and data collected. 
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the increased scientifi c diversity of proposals sometimes made 
it diffi  cult to identify appropriate UNC-CH faculty reviewers. 
This led us to initiate collaborations with local universities 
(Duke University and North Carolina State University). During 
the past year, we successfully completed mock reviews jointly 
with CTSAs at the University of Wisconsin and the University 
of Southern California (Phase IIIb). Notably, reviewers at UNC 
and other CTSA institutions have participated without fi nancial 
remuneration. Remarkably, we have had little diffi  culty convincing 
reviewers, both at UNC and at other institutions, to participate in 
the program.  We believe this is because they (or their mentees) 
have either directly benefi tted from mock reviews, they anticipate 
using the mock review program for their own proposals in the 
future, or they simply recognize the intrinsic value of the program. 
As we develop formal protocols for best practices for mock 
reviews, we will disseminate these practices throughout the CTSA 
Consortium. We recognize that, should faculty require payment 
to participate in activities, this may be a barrier to widespread 
implementation (especially for investigators outside their own 
institution). 
 K-seminar 
 In this required component of our KL2 program, Scholars 
use bi-weekly, one-hour K seminars to: present a “Works-in-
Progress” session; review ideas for grant proposals: rehearse 
national talks; receive feedback on draft  publications; review 
summary statements/discuss strategies for grant resubmission; 
and receive advice on their current research activities and overall 
career path. Specifi cally, these sessions allow Scholars to draw 
on the experiences of both peers and senior faculty as they 
develop their research proposals, thus enhancing the likelihood 
of receiving independent funding. As can be seen in  Figure  3 , we 
next invited Scholars from the Building Interdisciplinary Research 
Careers in Women’s Health (BIRCWH) K12 Program to attend K 
seminar alongside KL2 Scholars (Phase II). And, during the past 
5 years, we have integrated Scholars supported by three other 
institutional K12 Programs: Comparative Eff ective Research; 
Oncology; and Benign Hematology (Phase IIIa). Doing so has 
had several advantages, including: (1) fostering Scholars’ abilities 
to communicate across scientifi c disciplines, a skill essential for 
team science; (2) creating a forum for KL2/K12 Scholars to learn 
more about, and become engaged in, other types of research; 
(3) promoting collaboration among these Scholars; and (4) 
providing methodological and analytical input and advice from 
ETCD Biostatistics/Epidemiology Service faculty who attend 
these seminars. We applied the NC TraCS Education Development 
and Evaluation Model to pilot and evaluate new aspects of the K 
seminar. For example, although expanding our audience increased 
the diversity of attendees, the increased size posed challenges. We 
are in the process of introducing concurrent seminars in which 
Scholars meet in smaller groups, the composition of which will 
change during the year. Th is should allow Scholars to present more 
oft en (and therefore foster rapid progress), while still receiving 
input from colleagues in diff erent disciplines. If successful, we will 
identify another CTSA to evaluate the seminar across programs 
(Phase IIIb) and, ultimately, expand best practices for K-seminars 
across the CTSA consortium (Phase IV). 
 R-writing groups 
 Even with strong research training, it is oft en diffi  cult for junior 
investigators to transition to their fi rst independent investigator-
initiated research grant. To address this issue, we applied the NC 
TraCS Education Development and Evaluation Model to what 
is now our R-writing groups ( Figure  4 ). In 2008, we initiated a 
“K2R Writing Group” in which two senior faculty mentored six 
junior investigators (all former or current K-awardees) writing 
their fi rst R-type grant (Phase I). Th e initial goals, specifi ed in 
advance, were to provide a structure within which we could 
facilitate participants’ learning to both write their fi rst R-type 
grant and provide feedback to their peers. Qualitative feedback 
received during the formal evaluation revealed that while all 
participants learned much from working together, they thought 
that combining T1 and T2 researchers in the same group was 
suboptimal. Specifi cally, because R-type grant proposals for T1 
and T2 research diff ered substantially (e.g., role of preliminary 
data, specifi c aims, methodologies), participants reported being 
unable to contribute fully in developing and reviewing each 
other’s grants. In addition, participants stated that junior faculty 
would benefi t substantially from co-leading the group with a 
senior investigator. Th us, in 2009, the T1 group added a former 
 Figure 2.  NC TraCS Education Development and Evaluation Model applied to mock review program. 
 Figure 3.  NC TraCS Education Development and Evaluation model applied to K seminar. 
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participant (a past KL2 Scholar) who has his own independent 
funding as co-leader; and in 2010, we began a T2 group (Phase II) 
that also was co-led by a past KL2 Scholar. Having successful KL2 
Scholars participate as co-leaders provides them with leadership 
and mentoring experience that is vital to their long-term careers. 
Unlike mock reviews that involved a circumscribed activity, co-
leaders of R-writing groups provide a sustained commitment 
for approximately 9 months.  Th us, we provide ~10% salary 
support for each co-leader of the T1 and T2 groups. Notably, 
these more junior co-leaders will have the opportunity to develop 
their mentoring skills, which may be especially helpful for those 
planning to submit a mid-career mentoring award. We then 
expanded the opportunity to participate in the R-writing group 
to all junior investigators at UNC-CH, rather than restrict it to 
recipients of K-awards (Phase IIIa). Th e next step will be to identify 
another CTSA interested in working across institutions (Phase 
IIIb). A cross-CTSA program has many potential advantages 
(e.g., establishing long-term collaborations, providing faculty 
with specialized expertise); however, there are logistical and 
technical challenges to being in two locations. Perhaps more 
challenging is addressing participants’ and mentors’ concerns 
about sharing innovative ideas outside the applicant’s team and 
institution. Having participants sign confi dentiality agreements is 
one option to consider. Ultimately, if we can demonstrate interest 
and feasibility with another CTSA, we will seek to disseminate 
best practices across CTSAs that address the logistical, technical 
and scientifi c issues (Phase IV). 
 Discussion 
 The NIH Roadmap Initiative was launched to increase the 
speed with which basic science discoveries can be translated 
into real world practices that improve population health. Th e 
NIH recognized that achieving this goal meant that future 
interdisciplinary research teams would require diff erent training 
and ongoing career development. In developing innovative 
educational strategies to train and develop the careers of the future 
work force, we should not assume that what “makes sense” will 
work; neither should we assume that it will be simple to develop 
eff ective training strategies. Rather, we should have a deliberate, 
evidence-based plan to identify pragmatic best practices that can 
be disseminated across the CTSA Consortium. One example of 
such an approach is a randomized controlled trial conducted in 
16 CTSA sites demonstrating the eff ectiveness of a competency-
based research mentor training program. 7  
 Th e NC TraCS Education Development and Evaluation Model 
provides a blueprint for how one can systematically develop 
eff ective ETCD activities. It uses a 4-phase model (innovate, 
incubate, translate, disseminate) that parallels how areas such 
as drug and technology development systematically move from 
early stage fi ndings through postmarketing surveillance. As with 
drug development, our model outlines a strategy that allows 
for modifi cation, or even abandonment, as a response to new 
information. Th us, most activities will require refi nement along the 
way, and not all activities will proceed to the next phase. Decisions 
will be based upon formal evaluations. We have described three 
specifi c examples of how we applied this model to our ETCD 
programs. Notably, we have several other ETCD initiatives at 
various phases, including activities related to leadership, mentoring 
skills, and the responsible conduct of research. 
 Our approach seeks to address several challenges put forth 
by the IOM, especially the importance of innovative educational 
strategies and collaborating across the CTSA consortium. As we 
look forward, one challenge that we have not discussed is how to 
more eff ectively use rapidly evolving technology in education (e.g., 
online courses). However, that should be seen as yet another tool in 
our armamentarium and one that may provide an opportunity to 
leverage strengths of other CTSAs. Moreover, the ultimate success 
of our activities should be judged by our ability to disseminate 
evidence-based programs throughout the CTSA consortium. 
To date, we have not attempted Phase IV activities, but expect 
to do so soon. 
 Th is is an exciting time in clinical and translational science as 
we seek to rapidly disseminate research fi ndings into practices that 
improve population health. Th is enterprise depends on training 
team members and then retaining them as members of research 
teams. Th is is precisely why education training is critical to the 
overall success of the CTSA. 
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